Related Experiment Video
Updated: May 13, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Assessing bleeding risk in patients taking anticoagulants
1Division of Hospital Medicine, University of California, San Francisco, CA 94143, USA.
Journal of Thrombosis and Thrombolysis
|March 13, 2013
Summary
Anticoagulant medications prevent clots but increase bleeding risk. Current risk prediction tools offer modest accuracy but aid patient counseling and clinical decisions, especially for those at lower thromboembolic risk.
Area of Science:
- Pharmacology
- Clinical Medicine
- Biostatistics
Background:
- Anticoagulant medications are vital for preventing and treating thromboembolism.
- These drugs carry a significant risk of bleeding complications.
- Factors like advanced age, anemia, and renal disease increase hemorrhage risk.
Purpose of the Study:
- To evaluate the utility of clinical risk prediction tools for anticoagulant-associated hemorrhage.
- To assess the current effectiveness of these tools in quantifying bleeding risk.
Main Methods:
- Review of existing clinical risk prediction tools for anticoagulant-associated hemorrhage.
- Analysis of how these tools are derived, identify, and weight risk factors.
Main Results:
- Existing risk prediction tools demonstrate modest ability to accurately predict anticoagulant-associated hemorrhage.
- The influence of these tools is greatest in patients with lower thromboembolic risk.
Conclusions:
- Risk prediction tools can inform clinical decisions and patient counseling regarding anticoagulant therapy.
- These tools may identify patients who require more intensive anticoagulation management.
- Further refinement of risk prediction tools is needed to improve accuracy.
Related Concept Videos
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.